106 related articles for article (PubMed ID: 8289390)
1. Several E4 region functions influence mammary tumorigenesis by human adenovirus type 9.
Thomas DL; Schaack J; Vogel H; Javier R
J Virol; 2001 Jan; 75(2):557-68. PubMed ID: 11134268
[TBL] [Abstract][Full Text] [Related]
2. Structural Determinants within the Adenovirus Early Region 1A Protein Spacer Region Necessary for Tumorigenesis.
Molloy DP; Grand RJ
J Virol; 2020 Oct; 94(21):. PubMed ID: 32847858
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus type 18 chimeras containing the L2/L1 capsid genes from evolutionarily diverse papillomavirus types generate infectious virus.
Bowser BS; Chen HS; Conway MJ; Christensen ND; Meyers C
Virus Res; 2011 Sep; 160(1-2):246-55. PubMed ID: 21762735
[TBL] [Abstract][Full Text] [Related]
4. Comparative sequence analysis of the largest E1A proteins of human and simian adenoviruses.
Avvakumov N; Wheeler R; D'Halluin JC; Mymryk JS
J Virol; 2002 Aug; 76(16):7968-75. PubMed ID: 12134001
[TBL] [Abstract][Full Text] [Related]
5. Infectious virions produced from a human papillomavirus type 18/16 genomic DNA chimera.
Meyers C; Bromberg-White JL; Zhang J; Kaupas ME; Bryan JT; Lowe RS; Jansen KU
J Virol; 2002 May; 76(10):4723-33. PubMed ID: 11967289
[TBL] [Abstract][Full Text] [Related]
6. Early region 1 transforming functions are dispensable for mammary tumorigenesis by human adenovirus type 9.
Thomas DL; Shin S; Jiang BH; Vogel H; Ross MA; Kaplitt M; Shenk TE; Javier RT
J Virol; 1999 Apr; 73(4):3071-9. PubMed ID: 10074157
[TBL] [Abstract][Full Text] [Related]
7. E1A 12S and 13S of the transformation-defective adenovirus type 12 strain CS-1 inactivate proteins of the RB family, permitting transactivation of the E2F-dependent promoter.
Pützer BM; Rumpf H; Rega S; Brockmann D; Esche H
J Virol; 1997 Dec; 71(12):9538-48. PubMed ID: 9371617
[TBL] [Abstract][Full Text] [Related]
8. Identification of functional domains of adenovirus tumor-specific transplantation antigen in types 5 and 12 by viable viruses carrying chimeric E1A genes.
Sawada Y; Rasková J; Fujinaga K; Raska K
Int J Cancer; 1994 May; 57(4):598-603. PubMed ID: 8181863
[TBL] [Abstract][Full Text] [Related]
9. Genetically modified adenoviruses against gliomas: from bench to bedside.
Gomez-Manzano C; Yung WK; Alemany R; Fueyo J
Neurology; 2004 Aug; 63(3):418-26. PubMed ID: 15304571
[TBL] [Abstract][Full Text] [Related]
10. Constructing chimeric type 12/type 5 adenovirus E1A genes and using them to identify an oncogenic determinant of adenovirus type 12.
Telling GC; Williams J
J Virol; 1994 Feb; 68(2):877-87. PubMed ID: 8289390
[TBL] [Abstract][Full Text] [Related]
11. Tumorigenicity of adenovirus-transformed rodent cells is influenced by at least two regions of adenovirus type 12 early region 1A.
Jelinek T; Pereira DS; Graham FL
J Virol; 1994 Feb; 68(2):888-96. PubMed ID: 8289391
[TBL] [Abstract][Full Text] [Related]
12. Comparison between E1A gene from oncogenic and non-oncogenic adenoviruses in cellular transformation (Ad E1A conserved region).
Leclére V; Huvent I; Verwaerde P; Cousin C; D'Halluin JC
Arch Virol; 1993; 132(3-4):343-57. PubMed ID: 8379854
[TBL] [Abstract][Full Text] [Related]
13. E1A-based determinants of oncogenicity in human adenovirus groups A and C.
Williams JF; Zhang Y; Williams MA; Hou S; Kushner D; Ricciardi RP
Curr Top Microbiol Immunol; 2004; 273():245-88. PubMed ID: 14674604
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
